Baguley IJ, Perkes IE, Fernandez-Ortega JF, et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria[J]. J Neurotrauma, 2014, 31(17): 1515-1520.
[2]
Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis[J]. Lancet Neurol, 2011, 10(1): 63-74.
[3]
Pryzbylkowski PG, Dunkman WJ, Liu R, et al. Case report: Anti-N-Methyl-D-Aspartate receptor encephalitis and its anesthetic implications[J]. Anesth Analg, 2011, 113(5): 1188-1191.
[4]
Hinson HE, Takahashi C, Altowaijri G, et al. Anti-NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association[J]. Clin Auton Res, 2013, 23(2): 109-111.
[5]
Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-Daspartate-receptor encephalitis: diagnosis, optimal management, and challenges[J]. Ther Clin Risk Manag, 2014, 10: 517-525.
[6]
Fernandez-Ortega JF, Prieto-Palomino MA, Garcia-Caballero M, et al. Paroxysmal sympathetic hyperactivity after traumatic brain injury: clinical and prognostic implications[J]. J Neurotrauma, 2012, 29(7): 1364-1370.
[7]
Schroeppel TJ, Croce MA, Fabian TC. Re: Paroxysmal sympathetic hyperactivity, traumatic brain injury, and betablockers: Not all drugs are created equal[J]. J Trauma Acute Care Surg, 2014, 77(2): 387-388.
[8]
van de Riet EH, van Bronswijk SC, Schieveld JN. Movement disorders in anti-N-NMDA receptor encephalitis[J]. Tijdschr Psychiatr, 2015, 57(2): 109-113.
[9]
Baguley IJ. The excitatory:inhibitory ratio model (EIR model): An integrative explanation of acute autonomic overactivity syndromes[J]. Med Hypotheses, 2008, 70(1): 26-35.
[10]
Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies[J]. Lancet Neurol, 2008, 7(12): 1091-1098.
[11]
Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis[J]. J Neurosci, 2010, 30(17): 5866-5875.
[12]
Moscato EH, Jain A, Peng X, et al. Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies[J]. Eur J Neurosci, 2010, 32(2): 298-309.
Fernández-Ortega JF, Prieto-Palomino MA, Quesada-García G, et al. Findings in the magnetic resonance of paroxysmal sympathetic hyperactivity[J]. J Neurotrauma, 2011, 28(7): 1327-1328.
[15]
Wei L, Chen Y. Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson's disease[J]. Patient Prefer Adherence, 2014, 8: 271-273.
